{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:03:22Z","timestamp":1776708202271,"version":"3.51.2"},"reference-count":79,"publisher":"Impact Journals, LLC","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.18632\/oncotarget.19454","type":"journal-article","created":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T07:17:25Z","timestamp":1500794245000},"page":"60324-60341","source":"Crossref","is-referenced-by-count":55,"title":["Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe process"],"prefix":"10.18632","volume":"8","author":[{"given":"Szymon","family":"Kowalski","sequence":"first","affiliation":[{"name":"Department of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanis\u0142aw","family":"Ha\u0107","sequence":"additional","affiliation":[{"name":"Department of General, Endocrine and Transplantation Surgery, Medical University of Gdansk, Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Wyrzykowski","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, University of Gdansk, Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Zauszkiewicz-Pawlak","sequence":"additional","affiliation":[{"name":"Department of Histology, Medical University of Gdansk, Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Inkielewicz-St\u0119pniak","sequence":"additional","affiliation":[{"name":"Department of Medical Chemistry, Medical University of Gdansk, Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,7,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Bardeesy","year":"2014","journal-title":"N Engl J Med"},{"key":"4","first-page":"415","article-title":"Risk factors for pancreatic cancer: underlying mechanisms and potential targets","volume":"4","author":"Thrower","year":"2014","journal-title":"Front Physiol"},{"key":"5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/cge.12536","article-title":"Pancreatic cancer genomics: where can the science take us?","volume":"88","author":"Biankin","year":"2015","journal-title":"Clin Genet"},{"key":"6","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1016\/S1470-2045(13)70172-4","article-title":"Improvement of surgical results for pancreatic cancer","volume":"14","author":"B\u00fcchler","year":"2013","journal-title":"Lancet Oncol"},{"key":"7","first-page":"13","article-title":"Recent advances in pancreatic cancer: biology, treatment, and prevention","volume":"1856","author":"Shankar","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies","volume":"44","author":"Lowenfels","year":"2015","journal-title":"Int J Epidemiol"},{"key":"9","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Matrisian","year":"2014","journal-title":"Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Reni","year":"2013","journal-title":"N Engl J Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Stephens","year":"1997","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Khemissa-Akouz","year":"2011","journal-title":"N Engl J Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Bao","year":"2012","journal-title":"Cell Prolif"},{"key":"15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000336875","article-title":"Apoptosis-modulating drugs for improved cancer therapy","volume":"48","author":"H\u00f6pfner","year":"2012","journal-title":"Eur Surg Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/mc.22027","article-title":"FLIP: molecular switch between apoptosis and necroptosis","volume":"53","author":"Kumar","year":"2014","journal-title":"Mol Carcinog"},{"key":"17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2014.12.018","article-title":"Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target","volume":"94","author":"Diederich","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3264","article-title":"Killing a cancer: what are the alternatives?","volume":"12","author":"Watson","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5493\/wjem.v5.i4.206","article-title":"Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: significance for melanoma treatment","volume":"5","author":"Megahed","year":"2015","journal-title":"World J Exp Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/embor.2012.55","article-title":"Losing balance: the origin and impact of aneuploidy in cancer","volume":"13","author":"Cleveland","year":"2012","journal-title":"EMBO Rep"},{"key":"21","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1038\/sj.onc.1207873","article-title":"Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents","volume":"23","author":"Saya","year":"2004","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1054\/drup.2001.0213","article-title":"If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells","volume":"4","author":"Chang","year":"2001","journal-title":"Drug Resist Updat"},{"key":"23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.cell.2008.12.004","article-title":"Necroptosis: a specialized pathway of programmed necrosis","volume":"135","author":"Kroemer","year":"2008","journal-title":"Cell"},{"key":"24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.critrevonc.2011.08.004","article-title":"Necroptosis: an emerging form of programmed cell death","volume":"82","author":"Li","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/cdd.2010.72","article-title":"zVAD-induced necroptosis in L929 cells depends on autocrine production of TNF\u03b1 mediated by the PKC-MAPKs\u2013AP-1 pathway","volume":"18","author":"Shen","year":"2011","journal-title":"Cell Death Differ"},{"key":"26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature09878","article-title":"Functional complementation between FADD and RIP1 in embryos and lymphocytes","volume":"471","author":"Zhang","year":"2011","journal-title":"Nature"},{"key":"27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/ncb0910-823","article-title":"Autophagy in mammalian development and differentiation","volume":"12","author":"Levine","year":"2010","journal-title":"Nat Cell Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI73942","article-title":"Autophagy in cellular metabolism and cancer","volume":"125","author":"Thompson","year":"2015","journal-title":"J Clin Invest"},{"key":"29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Levine","year":"1999","journal-title":"Nature"},{"key":"30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Kroemer","year":"2008","journal-title":"Cell"},{"key":"31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1440-1746.2011.07008.x","article-title":"Obesity, autophagy and the pathogenesis of liver and pancreatic cancers","volume":"27","author":"Karin","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"33","first-page":"24","article-title":"Vanadium compounds in medicine","volume":"301","author":"Gambino","year":"2015","journal-title":"Coord Chem Rev"},{"key":"34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2010.01.030","article-title":"Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence","volume":"294","author":"Chatterjee","year":"2010","journal-title":"Cancer Lett"},{"key":"35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1248\/bpb.18.719","article-title":"Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds","volume":"18","author":"Sakurai","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1677\/joe.0.1260451","article-title":"Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats","volume":"126","author":"Kawada","year":"1990","journal-title":"J Endocrinol"},{"key":"37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s007750000182","article-title":"A new halogenated antidiabetic vanadyl complex, bis (5-iodopicolinato) oxovanadium (IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis","volume":"6","author":"Sakurai","year":"2001","journal-title":"J Biol Inorg Chem"},{"key":"38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4161\/auto.4600","article-title":"How to interpret LC3 immunoblotting","volume":"3","author":"Yoshimori","year":"2007","journal-title":"Autophagy"},{"key":"39","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.4155\/fmc.12.103","article-title":"The potentiality of vanadium in medicinal applications","volume":"4","author":"Rehder","year":"2012","journal-title":"Future Med Chem"},{"key":"40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00006676-198810000-00003","article-title":"Morphological and biochemical characterization of a human pancreatic ductal cell line (PANC-1)","volume":"3","author":"Michael","year":"1988","journal-title":"Pancreas"},{"key":"41","first-page":"1546","article-title":"Bis (4, 7-dimethyl-1, 10-phenanthroline) sulfatooxovanadium (IV) as a novel apoptosis-inducing anticancer agent","volume":"6","author":"Uckun","year":"2000","journal-title":"Clin Cancer Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00775-016-1389-0","article-title":"Bis (acetylacetonato)-oxidovanadium (IV) and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK\/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells","volume":"21","author":"Yang","year":"2016","journal-title":"J Biol Inorg Chem"},{"key":"43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1040-8428(01)00221-9","article-title":"Vanadium in cancer treatment","volume":"42","author":"Evangelou","year":"2002","journal-title":"Crit Rev Oncol Hemat"},{"key":"44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Brenner","year":"2007","journal-title":"Physiol Rev"},{"key":"45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.chemphyslip.2014.04.001","article-title":"Mitochondrial alterations in apoptosis","volume":"181","author":"Garc\u00eda-S\u00e1ez","year":"2014","journal-title":"Chem Phys Lipids"},{"key":"46","doi-asserted-by":"crossref","first-page":"3164734","DOI":"10.1155\/2016\/3164734","article-title":"The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults","volume":"2016","author":"Grzybowski","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"47","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/jcp.24385","article-title":"Therapeutic potential of a pyridoxal-based vanadium (IV) complex showing selective cytotoxicity for cancer versus healthy cells","volume":"228","author":"Pellecchia","year":"2013","journal-title":"J Cell Physiol"},{"key":"48","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00775-010-0668-4","article-title":"Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species","volume":"15","author":"Yang","year":"2010","journal-title":"J Biol Inorg Chem"},{"key":"49","first-page":"1053","article-title":"Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues","volume":"2","author":"Sandor","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0300-483X(00)00181-5","article-title":"A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines","volume":"147","author":"Etcheverry","year":"2000","journal-title":"Toxicology"},{"key":"51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00775-008-0387-2","article-title":"Vanadyl bisacetylacetonate induced G1\/S cell cycle arrest via high-intensity ERK phosphorylation in HepG2 cells","volume":"13","author":"Wang","year":"2008","journal-title":"J Biol Inorg Chem"},{"key":"52","first-page":"87","article-title":"The chemistry and biology of vanadium compounds in cancer therapeutics","volume":"301","author":"Salifoglou","year":"2015","journal-title":"Coord Chem Rev"},{"key":"53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ijc.22277","article-title":"Suppression of cell proliferation, induction of apoptosis and cell cycle arrest: chemopreventive activity of vanadium in vivo and in vitro","volume":"120","author":"Chatterjee","year":"2007","journal-title":"Int J Cancer"},{"key":"54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cbi.2006.08.006","article-title":"Vanadium mediated apoptosis and cell cycle arrest in MCF7 cell line","volume":"163","author":"Chatterjee","year":"2006","journal-title":"Chem Biol Interact"},{"key":"55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2014.05.018","article-title":"Sodium orthovanadate inhibits growth of human hepatocellular carcinoma cells in vitro and in an orthotopic model in vivo","volume":"351","author":"Jiang","year":"2014","journal-title":"Cancer Lett"},{"key":"56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","article-title":"Identification of RIP1 kinase as a specific cellular target of necrostatins","volume":"4","author":"Yuan","year":"2008","journal-title":"Nat Chem Biol"},{"key":"57","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4161\/cbt.26428","article-title":"The mechanism of necroptosis in normal and cancer cells","volume":"14","author":"Fulda","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"58","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2014.06.081","article-title":"The novel mTORC1\/2 dual inhibitor INK-128 suppresses survival and proliferation of primary and transformed human pancreatic cancer cells","volume":"450","author":"Chen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cell.2009.07.006","article-title":"RIP kinases at the crossroads of cell death and survival","volume":"138","author":"Vandenabeele","year":"2009","journal-title":"Cell"},{"key":"60","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2008.10.044","article-title":"Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway","volume":"135","author":"Yuan","year":"2008","journal-title":"Cell"},{"key":"61","volume-title":"Cell viability assays. Assay Guidance Manual","author":"Minor","year":"2016"},{"key":"62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1006\/abbi.1993.1311","article-title":"Characterization of the cellular reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction","volume":"303","author":"Tan","year":"1993","journal-title":"Arch Biochem Biophys"},{"key":"63","doi-asserted-by":"crossref","first-page":"e0130520","DOI":"10.1371\/journal.pone.0130520","article-title":"Necroptosis interfaces with MOMP and the MPTP in mediating cell death","volume":"10","author":"Molkentin","year":"2015","journal-title":"PLoS One"},{"key":"64","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","article-title":"Crosstalk between apoptosis, necrosis and autophagy","volume":"1833","author":"Tavernarakis","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"65","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1038\/ncb1101-e255","article-title":"Organelle-specific initiation of cell death pathways","volume":"3","author":"Kroemer","year":"2001","journal-title":"Nat Cell Biol"},{"key":"66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s004410000193","article-title":"The morphology of apoptosis","volume":"301","author":"H\u00e4cker","year":"2000","journal-title":"Cell Tissue Res"},{"key":"67","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4161\/auto.7.8.15762","article-title":"A critical role for autophagy in pancreatic cancer","volume":"7","author":"Kimmelman","year":"2011","journal-title":"Autophagy"},{"key":"68","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Pan","year":"2013","journal-title":"Cell Death Dis"},{"key":"69","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1634\/theoncologist.2014-0086","article-title":"Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma","volume":"19","author":"Spicer","year":"2014","journal-title":"Oncologist"},{"key":"70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","article-title":"Necroptosis as an alternative form of programmed cell death","volume":"22","author":"Yuan","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrm3115","article-title":"Mitotic catastrophe: a mechanism for avoiding genomic instability","volume":"12","author":"Kroemer","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"72","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1073\/pnas.0409130102","article-title":"DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/cdd.2011.96","article-title":"Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012","volume":"19","author":"Hengartner","year":"2012","journal-title":"Cell Death Differ"},{"key":"74","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/cdd.2008.47","article-title":"Death through a tragedy: mitotic catastrophe","volume":"15","author":"Zhivotovsky","year":"2008","journal-title":"Cell Death Differ"},{"key":"75","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4161\/auto.5.8.9896","article-title":"Autophagy, senescence and tumor dormancy in cancer therapy","volume":"5","author":"Gewirtz","year":"2009","journal-title":"Autophagy"},{"key":"76","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","article-title":"Cell death by mitotic catastrophe: a molecular definition","volume":"23","author":"Kroemer","year":"2004","journal-title":"Oncogene"},{"key":"77","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1387-7003(99)00180-X","article-title":"Synthesis, antiapoptotic biological activity and structure of an oxo-vanadium (IV) complex with an OOO ligand donor set","volume":"3","author":"Mealli","year":"2000","journal-title":"Inorg Chem Commun"},{"key":"78","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.poly.2010.08.015","article-title":"Comparison of the coordination capabilities of thiodiacetate and oxydiacetate ligands through the X-ray characterization and DFT studies of [V(O)(tda)(phen)]\u00b7 4H2O and [V(O)(oda)(phen)]\u00b7 1.5 H2O","volume":"29","author":"Galindo","year":"2010","journal-title":"Polyhedron"},{"key":"79","first-page":"1677","article-title":"Pharmacological and toxicological effects of co-exposure of human gingival fibroblasts to silver nanoparticles and sodium fluoride","volume":"9","author":"Radomski","year":"2014","journal-title":"Int J Nanomedicine"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:27:38Z","timestamp":1750786058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,22]]},"references-count":79,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2017,9,1]]}},"alternative-id":["19454","28947974"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19454","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,22]]}}}